Dokumendiregister | Terviseamet |
Viit | 11.1-12/24/8237-3 |
Registreeritud | 13.08.2024 |
Sünkroonitud | 14.08.2024 |
Liik | Sissetulev dokument |
Funktsioon | 11.1 Turustamise järgne järelevalve (post-marketing surveillance) |
Sari | 11.1-12 Turujärelevalvega seotud muu kirjavahetus („tahetakse infot“) - Nõustamine |
Toimik | 11.1-12/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | Becton, Dickinson and Company |
Saabumis/saatmisviis | Becton, Dickinson and Company |
Vastutaja | Jaak Raud (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: Richard Krantz <[email protected]>
Sent: Tue, 13 Aug 2024 10:48:20 +0000
To: "Meditsiiniseadmed (Medical Devices)" <[email protected]>
Subject: RE: Medical devices FSCA & FSN
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Thank you for a quick response!
Br,
Richard Krantz
Specialist Post Market Quality
Nordics
BD Restricted
Dear Richard Thank you for your inquiry! There is no requirement under the Estonian Medical Device Act for a handwritten signature from the customer who has received a Field Safety Corrective Action (FSCA) or Field Safety Notice (FSN). Only
ZjQcmQRYFpfptBannerStart
|
ZjQcmQRYFpfptBannerEnd
EXTERNAL EMAIL - Use caution opening attachments and links.
Dear Richard
Thank you for your inquiry!
There is no requirement under the Estonian Medical Device Act for a handwritten signature from the customer who has received a Field Safety Corrective Action (FSCA) or Field Safety Notice (FSN).
Only requirement for an FSN is stated in § 27. Registration of adverse incident and field safety notice:
(2) The field safety notice is drawn in Estonian with regard to medical devices made available on the Estonian market. Initial field safety notice submitted for an urgent situation may also be in English.
The key requirement is that the manufacturer can demonstrate that the customer has received and understood the FSCA or FSN. This can be achieved through various forms of electronic confirmation, such as emails, electronic signatures, or acknowledgment forms on a website.
What is crucial is that there is documented evidence showing that the customer has acknowledged receipt and understanding of the Field Safety Notice or corrective action.
If you have any further questions, please feel free to contact us.
Kind regards
Jaak Raud
Chief Specialist
Department of Medical Devices
+372 5561 0969
Republic of Estonia
Health Board
+372 794 3500
Paldiski mnt 81, 10614 Tallinn
Estonia
This e-mail is confidential and meant for use by the person named in the letterhead. Any use in any way or copying of it by a person not marked as the addressee thereof is prohibited. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments.
BD Restricted
Saatja: Richard Krantz <[email protected]>
Saatmisaeg: teisipäev, 13. august 2024 10:13
Adressaat: Meditsiiniseadmed (Medical Devices) <[email protected]>
Teema: Medical devices FSCA & FSN
Hi!
Is there a requirement for a handwritten signature from the customer or does some form of electronic confirmation work just as well when collecting response forms from customers who have received Field Safety Corrective Actions (FSCA) and Field Safety Notifications (FSN)?
Br,
Richard Krantz
Specialist Post Market Quality
Nordics
*******************************************************************
IMPORTANT MESSAGE FOR RECIPIENTS IN THE U.S.A.:
This message may constitute an advertisement of a BD group's products or services or a solicitation of interest in them. If this is such a message and you would like to opt out of receiving future advertisements or solicitations from this BD group, please forward
this e-mail to [email protected]. [BD.v1.0]
*******************************************************************
This message (which includes any attachments) is intended only for the designated recipient(s). It may contain confidential or proprietary information and may be subject to the attorney-client privilege or other confidentiality protections. If you are not a
designated recipient, you may not review, use, copy or distribute this message. If you received this in error, please notify the sender by reply e-mail and delete this message. Thank you.
*******************************************************************
Corporate Headquarters Mailing Address: BD (Becton, Dickinson and Company) 1 Becton Drive Franklin Lakes, NJ 07417 U.S.A.
BD Restricted